Meet The Advisers
Founder & CEO
Silvano Coletti, Engr.
25 years C-level experience in both private and public companies. World-class academic background in mathematics, and computational engineering. Leadership position in various EU-funded projects. Member of the Council at PRACE and scientific board member of academic organizations.
Advisory Board Member
Dr. Arieh Warshel
2013 Nobel Laureate, Chemistry.
Distinguished Professor of Chemistry, University Southern California (USC). Fellow of the National Academy of Sciences.
​
​
​
Chairman DrugReKindle initiative
Zsolt Lavotha
C-suite executive at major pharmaceutical companies, including Wyeth, Pfizer, Rhone Poulenc and Orexo. He brings a wealth of experience in global P&L management, finance, commercial operations and R&D. He managed successfully leading M&A and IPOs.
​
Advisory Board Member
Prof. Manuel Peitsch
CSO and senior director positions in big pharma companies. Founder and former Chair of the Swiss Institute of Bioinformatics (SIB). Professor for Bioinformatics, University of Basel.
​
Advisory Board Member
Junaid Baiwa, PhD, MD
Senior Partner, Head of UK, and Science Partner, Pioneering Intelligence. Visiting Scientist Harvard T.H. Chan School of Public Health. Ex Chief Medical Scientist, Microsoft.
​
Advisory Board Member
Paul Fehlner, PhD, JD
30 years of experience in the life sciences industry with deep expertise in intellectual property. He co-founded reVision Therapeutics to apply his expertise in IP to enhance the accessibility of medicines globally. Global head IP Novartis AG.
Advisory Board Member
Prof. Trevor Jones
CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW Visiting professor at King's College London and former Head of R&D at Wellcome. Distinguished career in the pharmaceutical and biotech industry as well as in academia.
​
​
Advisory Board Member
Jo Pisani
Formerly Head of UK Life Sciences, PwC and Chair, MedCity. Chair of Birmingham’s Precision Health Tech Accelerator. Several Life Sciences & Pharma board positions. As a rare disease patient for which there is a successfully repurposed drug she is a strong supporter of rare diseases and drug repurposing.
Communication Ambassador-at-large
James Beacham, PhD
Physicist at CERN: data scientist, science storyteller, quantum computing enthusiast, keynote speaker and communicator at the intersections of science, technology, innovation, society, and politics
​
​